Dr Ruth Thomas

Dr Ruth Thomas
BSc (Health Sciences), PhD

Research Fellow

Overview
Dr Ruth Thomas
Dr Ruth Thomas

Contact Details

Telephone
work +44 (0)1224 438172
Fax
fax +44 (0)1224 438165
Email
Address
The University of Aberdeen Centre for Healthcare Randomised Trials (CHaRT) Health Services Research Unit University of Aberdeen 3rd Floor, Health Sciences Building Foresterhill Aberdeen AB25 2ZD

Biography

Ruth Thomas is currently a Research Manager for the Centre Healthcare Randomised Trials (CHaRT), a fully registered UK Clinical Research Collaboration Clinical Trials Unit with an internationally recognised expertise in the design, conduct, analysis and reporting of multicentre trials.  Ruth joined the Unit in 1993.  She completed her PhD in the Unit in 2002 and went on to take up a Wellcome Trust Training Fellowship in Health Services Research which she completed in 2006. Ruth is a Health Services Researcher experienced in a range of HSR methods including systematic reviews, pragmatic RCTs (simple and complex), and other evaluative designs. Ruth previously worked on a series of "knowledge translation" evaluations ie getting evidence into clinical practice, involving complex rigorous designs.  

Research

Current Research

Ongoing research

Previous research

Research Grants

NIHR HS&DR 15/136/07 Multiple Symptoms Study 3: pragmatic trial of a community based clinic for patients with persistent (medically unexplained) physical symptoms. Start date: 1st February 2018 (42 months) Value: £1,193,035

NIHR HTA (13/152/02) The clinical and cost effectiveness of surgical interventions for stones in the lower pole calyces of the kidney: the PUrE RCT - Percutaneous Nephrolithotomy (PNL), Flexible Ureterorenoscopy (FURS) and Extracorporeal Shockwave Lithotripsy (ESWL) for lower pole calyceal kidney stones. Start date: 1st December 2015. (60 months). Value: £1,877,148.56.

Chief Scientists Office of the Scottish Government CZH/4/945 – Multiple Symptoms Study 2. A feasibility study to manualise, teach and demonstrate the delivery of the Symptoms Clinic intervention Start date: April 2014 (12 months). Value: £139,962.

NIHR HTA (10/137/01). Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. Start date: 1st March 2013 (48 months). Value: £1,426,755.

NIHR HTA (08/71/01) SUSPEND: Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multi centre placebo randomised trial. Start date: 1st June 2010 (42 months extended to 53 months). Value: £1,585,180 (+ 132,732).

NIHR HTA (07/47/01). The clinical effectiveness and cost-effectiveness of different surveillance mammography regimes after the treatment of primary breast cancer. Start date: 1st June 2008. Value: £239,474.

 

Further Info

Qualifications

PhD (Health Service Research, Public Health, University of Aberdeen)

BSc (Hons) (Health Sciences, University of Aberdeen)

ORCID

https://orcid.org/0000-0002-8316-2616

Publications

Publications 

Currently viewing:

Page 1 of 4 Results 1 to 10 of 38

  • Turner, S, Cotton, SC, Emele, CD, Thomas, RE, Fielding, SA, Gaillard, EA, de Jongste, JC, Morgan, HM, Nielson, AR, Norrie, J, Pijnenburg, MW, Price, DB & Thomas, M 2019, 'Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)' Trials.
  • McClinton, S, Cameron, S, Starr, K, Thomas, R, MacLennan, G, McDonald, A, Lam, T, N’Dow, J, Kilonzo, M, Pickard, R, Anson, K, Burgess, N, Clark, CT, MacLennan, S, Norrie, J & the TISU Study Group 2018, 'TISU: Extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones: study protocol for a randomised controlled trial' Trials, vol. 19, no. 1, 286, pp. 1-11. [Online] DOI: https://doi.org/10.1186/s13063-018-2652-1
  • Morton, L, Elliott, A, Thomas, R, Cleland, J, Deary, V & Burton, C 2016, 'Developmental study of treatment fidelity, safety and acceptability of a Symptoms Clinic intervention delivered by General Practitioners to patients with multiple medically unexplained symptoms' Journal of Psychosomatic Research, vol. 84, pp. 37-43. [Online] DOI: https://doi.org/10.1016/j.jpsychores.2016.03.008
  • Pickard, R, Starr, K, MacLennan, G, Lam, T, Thomas, R, Burr, J, McPherson, G, McDonald, A, Anson, K, N'Dow, J, Burgess, N, Clark, T, Kilonzo, M, Gillies, K, Shearer, K, Boachie, C, Cameron, S, Norrie, J & McClinton, S 2016, 'Kurzdarstellung aktueller publikationen: Begünstigt eine muskelrelaxierende therapie den uretersteinabgang?' Nieren- und Hochdruckkrankheiten, vol. 45, no. 1, pp. 38.
  • Pickard, R, Starr, K, MacLennan, G, Kilonzo, M, Lam, T, Thomas, RE, Burr, J, Norrie, J, McPherson, G, McDonald, A, Shearer, K, Gillies, K, Anson, K, Boachie, C, N'Dow, J, Burgess, N, Clark, T, Cameron, S & McClinton, S 2015, 'Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)' Health Technology Assessment, vol. 19, no. 63. [Online] DOI: https://doi.org/10.3310/hta19630
  • Pickard, R, Starr, K, MacLennan, G, Lam, TBL, Thomas, RE, Burr, J, McPherson, G, McDonald, A, Anson, K, N'Dow, JMO, Burgess, N, Clark, T, Kilonzo, M, Gillies, K, Shearer, K, Boachie, C, Cameron, S, Norrie, J & McClinton, S 2015, 'Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial' The Lancet, vol. 386, no. 9991, pp. 341-349. [Online] DOI: https://doi.org/10.1016/S0140-6736(15)60933-3
  • McClinton, S, Starr, K, Thomas, R, MacLennan, GS, McPherson, G, McDonald, A, Lam, T, N'Dow, J, Kilonzo, M, Pickard, R, Anson, K, Burr, J & SUSPEND Study Group 2014, 'Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial' Trials, vol. 15, no. 1, 238. [Online] DOI: https://doi.org/10.1186/1745-6215-15-238
  • Eccles, MP, Grimshaw, JM, MacLennan, G, Bonetti, D, Glidewell, L, Pitts, NB, Steen, N, Thomas, RE, Walker, A & Johnston, M 2012, 'Explaining clinical behaviors using multiple theoretical models' Implementation Science, vol. 7, 99. [Online] DOI: https://doi.org/10.1186/1748-5908-7-99
  • Glidewell, E, Johnston, M & Thomas, RE 2012, 'Shared understandings of dementia? An application of the Common Sense Self Regulation Model to a case study' Dementia: the international journal of social research and practice, vol. 11, no. 2, pp. 217-250. [Online] DOI: https://doi.org/10.1177/1471301211416611
  • Robertson, C, Ragupathy, SKA, Boachie, C, Fraser, C, Heys, SD, Maclennan, G, Mowatt, G, Thomas, RE, Gilbert, FJ & Mammographic Surveillance Health Technology Assessment Group 2011, 'Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review' European Radiology, vol. 21, no. 12, pp. 2484-2491. [Online] DOI: https://doi.org/10.1007/s00330-011-2226-z
Show 10 | 25 | 50 | 100 results per page

Update